WebOur leadership is grounded in cutting-edge innovation and breakthrough technology, transforming the way we treat eye diseases and eye conditions. We have the widest array of eye care offerings in the industry with products organized into two business: Surgical and Vision Care. Surgical Vision Care Investor Relations WebAlomide® (lodoxamide tromethamine ophthalmic solution) 0.1% (lodoxamide tromethamine ophthalmic solution) Resources Prescribing Information (PDF 84.54 KB) Patient Assistance Arranon® (nelarabine) (injection) Resources Prescribing information (PDF 289.68 KB) Patient Assistance Arzerra® (ofatumumab) (injection, for intravenous use) Resources
Novartis to acquire Xiidra®, expanding front-of-eye …
WebMay 9, 2024 · Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care May 09, 2024 Xiidra (lifitegrast ophthalmic solution) 5% fits strategically within industry-leading USD 4.6 billion Novartis ophthalmic pharmaceutical portfolio, laying groundwork for front-of-the-eye pipeline products currently in … WebApr 14, 2024 · Position: Sales / Sr Sales Specialist – Eye Care – College Park MD – Remote 10 major new medicines planned for launch over the next few years creating … irish nationalism vs irish republicanism
Novartis buys Gyroscope for $1.5 bln to add new …
WebOct 8, 2024 · Basel, October 8, 2024 — Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Beovu® (brolucizumab) injection, also known as RTH258 for the treatment of wet age-related macular degeneration (AMD) [1]. WebClinical Trials Novartis Clinical Trials Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, … WebNovartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; production ceased 2024), terbinafine (Lamisil), deferasirox … irish nationality and citizenship act 2004